Insights from a proteomic atlas of human Alzheimer's disease brain tissue
Tomas Kavanagh
Eleanor Drummond
Abstract：There is an urgent need to identify new drug targets for Alzheimer's disease (AD). While new immunotherapies show promise, clinical benefit appears low, and side effects are high. A greater understanding of the disease mechanisms driving AD is an essential factor that will facilitate the identification of new, effective drug targets.
Machine-generated Keywords：
Publication Date：2025-03-27
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 799-800 )